Drug susceptibility assay measuring SYBR®Green I fluorescence in laboratory strains and field isolates
IMPORTANT NOTICE: Although WWARN uses reasonable care when documenting protocols and procedures, its liability for any content (or the use made of it) is necessarily limited. Some protocols and procedures have been designed as templates which can be modified and used by local investigators, field staff and researchers. Such templates do not contain every available consideration and may be affected by circumstances that could not have been anticipated or taken into account in generating them. Accordingly, WWARN and its contributors cannot accept any liability for any loss arising as a result of any reliance placed on these protocols and procedures.
You may copy, modify, distribute and generally re-use these protocols and proceduresfor non-commercial purposes, provided such use includes the following statement: "This [procedure/protocol] was developed from a template document generated by the WorldWide Antimalarial Resistance Network (WWARN). The original document is available on the WWARN www.wwarn.org."
This document provides guidance for a general process for collecting the standard 12-lead clinical trial ECG data, to support any trial-specific instructions. It does not include ambulatory (e.g. Holter) ECGs. The document, which is not prescriptive, may be adapted by sites as required.
This document describes the procedure for proper measurement and recording of tympanic membrane body temperature using the Braun ThermoScan in patients enrolled in clinical malarial studies to detect fever and monitor reponse to antimalarial therapy